[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"WSJ track record off the top of my head: $MRK / $PFE / $SGEN $NVS / $CYTK (ha) $MRK / $XLRN $AMGN / $HZNP $MRK / $RXDX $GILD / $IMMU $JNJ / $SWAV $PFE/ $GBT"
X Link @fakepharmabro 2025-10-10T15:31Z 2840 followers, 1636 engagements
"@ForestViewCap Based on the acquisition multiples of $SWAV $NARI and OrganOx I doubt Waleed and the board would sell for less than 11x NTM revs which would put the stock price at approx $XXX per share"
X Link @JonahLupton 2025-09-09T17:46Z 566.5K followers, 1600 engagements
"@Mike73030190 If they got acquired it would have to be at 12x NTM revs or higher otherwise no chance Waleed and the board are selling the company. $SWAV got acquired for 13x NTM revs which is the best comp we have over past few years in medtech"
X Link @JonahLupton 2025-08-10T19:27Z 566.5K followers, 2001 engagements
"$TMDX trading at less than 6x NTM revs with revs growing XX% YoY and XX% EBITDA margins. $SWAV got acquired for 13x NTM revs with revs growing XX% and XX% EBITDA margins. $STAA got acquired for 6x NTM revs with revs growing -XX% YoY and -XX% EBITDA margins. $TMDX is 40-50% undervalued at current prices relative to where I see fundamentals going over the next 2-3 years"
X Link @JonahLupton 2025-08-10T17:49Z 566.5K followers, 1876 engagements